Dr. Rachel Hitt, MD
Claim this profileUniversity of North Carolina at Chapel Hill
Studies Breast Cancer
1 reported clinical trial
1 drug studied
Affiliated Hospitals
Clinical Trials Rachel Hitt, MD is currently running
More about Rachel Hitt, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Rachel Hitt, MD has experience with
- Iohexol 350 Mg/mL Injectable Solution
Breakdown of trials Rachel Hitt, MD has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Hitt, MD specialize in?
Rachel Hitt, MD focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved treating patients, or patients who are undergoing treatment.
Is Rachel Hitt, MD currently recruiting for clinical trials?
Yes, Rachel Hitt, MD is currently recruiting for 1 clinical trial in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Rachel Hitt, MD has studied deeply?
Yes, Rachel Hitt, MD has studied treatments such as Iohexol 350 Mg/mL Injectable Solution.
What is the best way to schedule an appointment with Rachel Hitt, MD?
Apply for one of the trials that Rachel Hitt, MD is conducting.
What is the office address of Rachel Hitt, MD?
The office of Rachel Hitt, MD is located at: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States. This is the address for their practice at the University of North Carolina at Chapel Hill.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.